Form 4: Atlanta Braves Holdings Executive Sells $3.1 Million in Stock Following Option Exercises
Insider Transaction Report
Derek Gordon Schiller, EVP of Business at Atlanta Braves Holdings, Inc., reported the exercise of stock options and subsequent sale of 70,000 shares of Series C Common Stock for approximately $3.1 million, executed under a pre-arranged 10b5-1 plan.
Summary
- Derek Gordon Schiller, Executive Vice President of Business at Atlanta Braves Holdings, Inc. (BATRK), reported transactions involving Series C Common Stock.
- On June 18, 2025, Mr. Schiller exercised options to acquire 40,000 shares of Series C Common Stock at an exercise price of $27.18 per share.
- Concurrently on June 18, 2025, he sold 40,000 shares of Series C Common Stock at a price of $44.00 per share.
- On June 20, 2025, Mr. Schiller exercised options to acquire an additional 30,000 shares of Series C Common Stock at an exercise price of $27.18 per share.
- Also on June 20, 2025, he sold 15,000 shares at $45.00 per share and another 15,000 shares at $46.00 per share.
- All sales were conducted pursuant to a Rule 10b5-1 sales plan adopted by Mr. Schiller on September 6, 2024.
- Following these transactions, Mr. Schiller's direct beneficial ownership of Series C Common Stock stands at 300,233 shares.
- His remaining stock options (Right to Buy) for BATRK are 175,395, with an exercise price of $27.18 and an expiration date of December 10, 2027.
Sentiment
Score: 5
Explanation: The sentiment is neutral to slightly negative. While insider selling can sometimes be viewed negatively, the fact that these sales were pre-planned under a Rule 10b5-1 plan mitigates concerns that the executive is selling due to a lack of confidence in the company's future prospects. The transactions are a routine part of executive compensation and financial planning.
Positives
- The executive realized a significant profit from exercising options at $27.18 and selling shares at prices ranging from $44.00 to $46.00, indicating a favorable return on his equity compensation.
- The sales were conducted under a pre-arranged Rule 10b5-1 plan, which suggests the transactions were scheduled in advance and not based on new, non-public information, potentially mitigating negative market interpretations of insider selling.
Negatives
- The transactions represent a reduction in the executive's direct beneficial ownership of Series C Common Stock by 70,000 shares, which could be perceived as a decrease in insider alignment with shareholder interests, despite being pre-planned.
Future Outlook
This Form 4 filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic outlook.
Industry Context
This filing is an insider transaction report (Form 4), which details equity transactions by a company executive. It does not provide information related to broader industry trends or competitive landscape, focusing solely on the individual's stock activity within Atlanta Braves Holdings, Inc.
Related Party Transactions
- The reported transactions are related party dealings as they involve an executive (Derek Gordon Schiller) of Atlanta Braves Holdings, Inc. trading the company's securities.
Stakeholder Impact
- Shareholders: May view the insider selling with slight caution, but the disclosure of a Rule 10b5-1 plan helps to alleviate concerns that the sales are based on negative undisclosed information. The executive's remaining beneficial ownership and options still represent a significant stake.
- Employees: No direct impact indicated by this filing.
- Customers: No direct impact indicated by this filing.
- Suppliers: No direct impact indicated by this filing.
- Creditors: No direct impact indicated by this filing.
Key Dates
| Date | Description |
|---|---|
| 12/10/2023 | Date stock options became exercisable. |
| 09/06/2024 | Date Rule 10b5-1 sales plan was adopted by the reporting person. |
| 06/18/2025 | Transaction date for the exercise of 40,000 stock options and subsequent sale of 40,000 shares of Series C Common Stock. |
| 06/20/2025 | Transaction date for the exercise of 30,000 stock options and subsequent sale of 30,000 shares of Series C Common Stock. |
| 06/23/2025 | Signature date of the Form 4 filing. |
| 12/10/2027 | Expiration date of the stock options. |
Recommendation
holdKeywords
Atlanta Braves Holdings, BATRK, SEC Form 4, Insider Trading, Stock Option Exercise, Stock Sale, Rule 10b5-1 Plan, Executive Compensation, Equity Transactions
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.